Suppr超能文献

基于肝硬度对一般人群中酒精性和非酒精性脂肪性肝病高危个体的鉴别:一项横断面研究。

Discrimination of individuals in a general population at high-risk for alcoholic and non-alcoholic fatty liver disease based on liver stiffness: a cross section study.

机构信息

Hokkaido Social Insurance Hospital, Center for Gastroenterology and Hepatology, Sapporo, Japan.

出版信息

BMC Gastroenterol. 2011 Jun 13;11:70. doi: 10.1186/1471-230X-11-70.

Abstract

BACKGROUND

Factors associated with liver stiffness (LS) are unknown and normal reference values for LS have not been established. Individuals at high risk for alcoholic (ALD) and non-alcoholic fatty (NAFLD) liver disease need to be non-invasively discriminated during routine health checks. Factors related to LS measured using a FibroScan and normal reference values for LS are presented in this report.

METHODS

We measured LS using a FibroScan in 416 consecutive individuals who presented for routine medical checks. We also investigated the relationship between LS and age, body mass index (BMI), liver function (LF), alcohol consumption, and fatty liver determined by ultrasonography. We identified individuals at high-risk for ALD and NAFLD as having a higher LS value than the normal upper limit detected in 171 healthy controls.

RESULTS

The LS value for all individuals was 4.7 +/- 1.5 kPa (mean +/- SD) and LS significantly and positively correlated with BMI and LF test results. The LS was significantly higher among individuals with, than without fatty liver. Liver stiffness in the 171 healthy controls was 4.3 +/- 0.81 kPa and the upper limit of LS in the normal controls was 5.9 kPa. We found that 60 (14.3%) of 416 study participants had abnormal LS. The proportion of individuals whose LS values exceeded the normal upper limit was over five-fold higher among those with, than without fatty liver accompanied by abnormal LF test results.

CONCLUSIONS

Liver stiffness could be used to non-invasively monitor the progression of chronic liver diseases and to discriminate individuals at high risk for ALD and NAFLD during routine health assessments.

摘要

背景

与肝硬度(LS)相关的因素尚不清楚,LS 的正常参考值尚未建立。在常规健康检查中,需要对酒精性(ALD)和非酒精性脂肪性(NAFLD)肝病高危个体进行非侵入性鉴别。本报告介绍了使用 FibroScan 测量的 LS 相关因素和 LS 的正常参考值。

方法

我们对 416 例因常规医疗检查就诊的连续个体使用 FibroScan 测量 LS,并探讨了 LS 与年龄、体重指数(BMI)、肝功能(LF)、酒精摄入和超声检查确定的脂肪肝之间的关系。我们将 ALD 和 NAFLD 高危个体定义为 LS 值高于 171 例健康对照的正常上限。

结果

所有个体的 LS 值为 4.7 +/- 1.5 kPa(平均值 +/- SD),LS 与 BMI 和 LF 检测结果显著正相关。有脂肪肝的个体 LS 显著高于无脂肪肝的个体。171 例健康对照者的 LS 为 4.3 +/- 0.81 kPa,正常对照者 LS 的上限为 5.9 kPa。我们发现 416 例研究参与者中有 60 例(14.3%) LS 异常。伴有异常 LF 检测结果的脂肪肝患者 LS 值超过正常上限的个体比例是无脂肪肝患者的五倍以上。

结论

肝硬度可用于非侵入性监测慢性肝病的进展,并在常规健康评估中鉴别 ALD 和 NAFLD 高危个体。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7071/3154156/aeb2e82768b3/1471-230X-11-70-1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验